Across TCGA pan-cancer cohorts, RPSAP10 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPSAP10’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPSAP10 RNA is repressed in tumor relative to normal tissue. In most cancer types RPSAP10 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

KIRC and PRAD are the cancer types where RPSAP10 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPSAP10 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	II,III,IV	−0.031	.010	6	view →
PRAD	All	All	+0.047	.004	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RPSAP10 RNA expression & survival · all RPSAP10 data types